Award
NIH Reporter #5F31DK141224-03
Evolution of B Lymphocyte Insulin Autoantigen Recognition in Type 1 Diabetes
Recipient
Vanderbilt University
Award Amount
$35,435.00
Ceiling
$35,435.00
Awarded
August 11, 2026
Identifier
5F31DK141224-03
NIH-funded project by Vanderbilt University studying B lymphocyte insulin autoantigen recognition in type 1 diabetes to identify early immunotherapy response indicators, supporting investigator career development.
Description
The project focuses on the evolution of B lymphocyte recognition of insulin in type 1 diabetes. It involves advanced human hybridoma technology and single cell technology to identify early indicators of immunotherapy response. The project is funded by the NIH, specifically the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and aims to support the future career of the investigator as an independent scientist in immunotherapy design.